NCT05036252 2025-09-30
Study of Cardiopulmonary Exercise Testing in Women Who Have HER2-Positive Breast Cancer With Mild Cardiotoxicity
Memorial Sloan Kettering Cancer Center
Active not recruiting
Clinical Trials
5 trialsNCT06069115 2025-02-11
RELIEF-COHORT
Meshalkin Research Institute of Pathology of Circulation
Recruiting
NCT03510689 2024-10-16
Gene-HEART
Abramson Cancer Center at Penn Medicine
Completed
NCT02615054 2024-04-11
Assessment for Long-Term Cardiovascular Impairment Associated With Trastuzumab Cardiotoxicity in HER2-Positive Breast Cancer Survivors
Memorial Sloan Kettering Cancer Center
Completed
NCT02702830 2019-04-26
MRI and Cardio-Pulmonary Exercise Testing in Evaluating Exercise Intolerance in Patients With Stage I-III Breast Cancer After Chemotherapy Treatment
Wake Forest University Health Sciences
Completed